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Abstract 
Effective method development together with method`s eco-friendly character are gaining 
importance in drug analyses nowadays. One of the strategies often applied to improve the efficacy 
of separation methods, especially in the case of basic ionizable analytes is adding chaotropic salts 
into the mobile phases. Moreover, the development of the green liquid chromatography method 
could also be achieved with certain mobile phase additives such as cyclodextrin (CD). The study 
aims to investigate whether adding chaotropic agents could improve the complexation process by 
disrupting the analytes’ water solvation shell. The model mixture consisted of risperidone, 
olanzapine, and their related impurities. Method development was aided with experimental design 
methodology, while optimal separation conditions were selected using Derringer’s desirability 
function. Mathematical models obtained for each of the examined responses enabled the 
explanation of the single and simultaneous influence of β-CD concentration, chaotropic agents 
type, and content, as well as the content of acetonitrile in the mobile phase. Retention factors 
appeared to be the most influenced by acetonitrile content in the mobile phase. The type of 
chaotropic agent as well as its concentration lead to retention prolongation, but if acetonitrile 
content in the mobile phase is high, the effect of chaotropic agent becomes negligible. Interaction 
between analyte and β-CD are relatively weak in comparison to the interaction of analyte form 
with either chaotropic agent or acetonitrile. Interaction leading to complexation are outperformed 
by other analyte related interactions in this complicated system, so complexation based retention 
reduction is not fully exposed. However, increasing β-CD concentration shows a positive effect 
on the resolution between critical peak pairs. Optimal separation conditions were selected based 
on 3D plots of Derringer’s desirability function. For olanzapine and its impurity, they included 
the following: acetonitrile content 16% (v/v), trifluoroacetic acid as a chaotropic agent with 0.95% 
(v/v) content, and 9 mM β-CD concentration. Further, optimal separation conditions for 
risperidone and its impurity were 25% (v/v) acetonitrile content in the mobile phase, 
trifluoroacetic acid as chaotrope agent with 0.27% (v/v) content and 5mM β-CD concentration. 
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Introduction 
Liquid chromatography, usually considered a universal technique, has certain 
advantages over other chromatographic techniques which made it the most applied one. 
Its advantages are reflected in high precision and easily available instruments and 
columns. Knowing the characteristics of most analytes, reversed-phase High Performance 
Liquid Chromatography (RP-HPLC) is the most frequently used in the drug analysis (1). 
Keeping up with the advances in HPLC, there is a constant need for improvement of its 
efficacy on one hand, and its ecological acceptability on the other hand. Therefore, there 
are different strategies used to modify the present HPLC methods to meet the new 
standards.  
Effective method development in drug analyses leads to an increased investigation 
of different mobile phase additives and its influence on retention behaviour, especially in 
the case of ionizable analytes (2). If analytes are basic, mobile phase additives such as 
ion-pairing reagents are the most frequently used. However, due to certain limitations in 
their suitability, inorganic salts, called chaotropic salts, took the leading role (3). 
Chaotropic salts got the name after their activity of order breaking, namely they can 
disrupt the analyte solvation shell thus strengthening the hydrophobic interactions (3, 4). 
Mobile phases with chaotropic salts could influence the retention of protonated basic 
analytes in RP-HPLC, in terms of retention prolongation. In the same way, an increase in 
peak symmetry and efficiency would occur (3, 5).  
On the other hand, developing a green RP-HPLC method has become an ultimate 
goal in drug analyses nowadays. Among the available strategies, there are ones including 
usage of mobile phase additives, such as cyclodextrin (CD). CDs are widely used as 
mobile phase additives due to their ability to incorporate different organic compounds 
within the cavity (6, 7). Consequently, inclusion complexation leads to changes in 
physicochemical characteristics of incorporated analytes, reducing its retention (8). 
Reduction in analyte retention time causes shorter analyses and low organic solvent 
consumption, which is contributing to eco-friendly postulates (9). In CD-modified RP-
HPLC systems, the binding process between the host CD cavity and the guest molecule 
is not permanent, but rather represents a dynamic equilibrium (10). Water molecules 
surrounding the hydrophobic CD cavity are inducing the complex formation by the 
exchange of these enthalpy-rich water molecules from the cavity with hydrophobic guest 
molecules in the solution (11). There are different ways to relocate the equilibrium in the 
complex formation direction. Namely, the complex formation can be induced by 
supplanting the water molecules from the  hydrophobic CD cavity followed by forming 
many hydrogen bonds along with returning the water molecules to the pool. Moreover, 
the decrease of repulsive forces between aqueous solution and hydrophobic guest 
molecule as well as the increase in hydrophobic interactions upon insertion of the guest 
molecule into the CD cavity could lead to host-guest complex formation (10). Having in 
mind the aforementioned, β-CD complexation process could be affected with CD type 
and cavity size, together with pH and ionization state of the guest molecule, and other 
additives present in the mobile phase. Therefore, the study aimed to analyze whether 
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added chaotropic agents would affect the complexation process by disrupting the water 
shell and thus strengthening the interactions leading to complex formation. Among 
different CDs, β-CD was used for this study, while risperidone, olanzapine, and their 
related impurities were selected as model substances (Figure 1).   
 
Figure 1. Chemical structures of risperidone and its related impurity, as well as olanzapine  
 and its related impurity 
Slika 1.  Hemijske strukture risperidona i njegove srodne supstance i olanzapina i  
 njegove srodne supstance 
 
Experimental 
Chemicals and reagents 
Reference standard substances of risperidone and its related impurity were obtained 
from Jannsen Pharmaceutical N.V. (Beerse, Belgium), while olanzapine and its related 
impurity reference standard substances were from USP – U.S. (Rockwil, USA). β-CD 
was purchased from Sigma Aldrich Chemie GmbH (Taufkirchen, Germany). Perchloric 
and trifluoroacetic acid, used as chaotropic agents, were obtained from Riedel-de Haën 
AG (Seelze, Germany). HPLC grade acetonitrile was from Sigma Aldrich Chemie GmbH 
(Taufkirchen, Germany). Deionized HPLC water was produced by using Simplicity 185 
purification system, Millipore (Billerica, USA). pH of the aqueous part of the mobile 
phase was adjusted by adding an appropriate amount of formic or acetic acid Sigma 
Aldrich Chemie GmbH (Taufkirchen, Germany).  
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Instruments and chromatographic conditions 
Experiments were performed on Dionex Ultimate 3000 (Thermo Fisher Scientific, 
USA) equipped with a Photodiode array detector (PDA). Analyte’s separation was 
achieved on monolithic C18 column Chromolith performance RP-18e (100 x 4.6 mm, 
2µm macropore size, 13 nm mesopore size) (Merck, Germany) at the temperature set to 
25°C. A pH-meter with the combined electrode (PHM 210, Radiometer, Denmark) was 
used to adjust the pH of the prepared solutions. Before use, all mobile phases were filtered 
through membrane filter 0,45 µm pore size (Agilent Technologies, Germany). Detection 
was performed at 285 nm. The flow rate was set to 1 mL min-1, while the injection volume 
was 10 µL.  
Aqueous mobile phases were prepared by dissolving the appropriate amount of β-
CD in water (5-15mM) and adding either perchloric or trifluoroacetic acid in the 
appropriate percentage (0.1-1%).  
Preparation of stock and working solutions 
Risperidone, olanzapine, and their impurities stock solutions were prepared by 
dissolving the appropriate amount of reference standard substance in the mixture of 
acetonitrile and water 50:50 (v/v) to obtain the concentration of 1 mg mL-1. Stock 
solutions of olanzapine and its related impurity were kept protected from sunlight due to 
their susceptibility to photodegradation. Working solutions were prepared by taking an 
appropriate volume of stock solutions and dissolving it in the mobile phase. 
Concentrations of risperidone and its impurity working solutions were  150 μg mL-1 and 
50 μg mL-1, respectively. Olanzapine and its impurity working solutions were prepared 
following the same procedure and in the same concentrations as in the case of risperidone 
and its impurity. Inclusion complexes formation in the solution was induced by mixing 
the working solutions on a Vortex mixer for 30 minutes prior to analyses.  
Experimental plan 
Experimental plan was created using Design Expert 7.0.0. software Stat-Ease, Inc. 
(Minneapolis, USA). Preliminary experiments were performed to define the factor 
ranges, while experimental space was properly covered by applying central composite 
design.  
Results and discussion  
Central composite design, as response surface type of experimental design, was 
used to define the experimental space and choose optimal conditions for the separation of 
risperidone and its impurity, as well as olanzapine and its impurity. In order to choose the 
factors which would be optimized through CCD, preliminary investigations were 
conducted. Based on the preliminary experiments the following numerical factors were 
included in the experimental design: acetonitrile content (%, v/v), β-CD concentration 
(mM), and chaotropic ion concentration (%, v/v). Selected factors and their corresponding 
domains are presented in Table I.  
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Table I  Investigated factors and their corresponding levels 




-1 0 +1 
Acetonitrile content 
(%, v/v) 




0.1 0.55 1 
β-CD concentration 
(mМ) 
5 10 15 
 
Together with numeric factors, the type of chaotropic agent (trifluoroacetic or 
perchloric acid), was included in the design as a categorical variable. Table II 
(supplementary at the end of the paper) shows the obtained experimental plan as well as 
responses that were followed. Responses included retention factors (k) and peak width of 
all investigated analytes, as well as resolutions between risperidone and its impurity, and 
olanzapine and its impurity. The relation between change in response influenced by a 
change in the value of the factors is characterised by a mathematical model. For each of 
the responses Design- Expert software suggested separate mathematical models. 
 
Table II  Experimental plan obtained by applying CCD (supplementary material) 
























































































































































































































1 5 15 0.1 TFA 3.04 4.59 14.57 10.04 1.38 2.87 0.54 0.46 2.27 1.11 
2 15 15 0.1 TFA 3.61 4.24 11.98 9.16 1.43 2.35 0.47 0.42 1.66 0.88 
3 5 25 0.1 TFA 1.90 1.99 3.13 2.49 0.00 2.89 0.36 0.12 0.33 0.23 
4 15 25 0.1 TFA 3.16 1.92 3.04 2.53 0.00 2.87 0.21 0.09 0.39 0.16 
5 5 15 1 TFA 6.32 13.02 39.03 19.73 2.35 10.24 0.93 0.99 2.84 1.79 
6 15 15 1 TFA 8.88 11.48 31.31 17.19 2.19 9.89 0.87 0.89 2.00 1.22 
7 5 25 1 TFA 2.47 2.67 4.58 3.39 1.07 5.27 0.18 0.17 0.40 0.26 
8 15 25 1 TFA 3.50 1.87 5.30 3.39 0.99 6.46 0.18 0.15 0.43 0.10 
























































































































































































































10 15 20 0.55 TFA 7.99 3.95 9.55 5.85 1.42 5.97 0.29 0.29 0.76 0.42 
11 10 15 0.55 TFA 2.20 9.57 24.96 15.37 2.26 5.33 0.66 0.68 2.30 1.16 
12 10 25 0.55 TFA 2.02 2.32 3.97 2.83 0.88 3.84 0.13 0.12 0.35 0.21 
13 10 20 0.1 TFA 3.84 2.33 5.33 4.04 0.88 2.43 0.17 0.17 0.74 0.37 
14 10 20 1 TFA 4.36 4.36 10.91 6.24 1.57 6.60 0.32 0.32 0.90 0.46 
15 10 20 0.55 TFA 3.07 2.99 7.65 4.89 1.27 5.34 0.14 0.24 0.75 0.39 
16 10 20 0.55 TFA 2.65 4.01 8.32 5.09 1.45 5.12 0.35 0.27 0.68 0.38 
17 10 20 0.55 TFA 3.05 3.78 6.87 5.58 1.02 4.25 0.32 0.22 0.77 0.41 
18 10 20 0.55 TFA 3.45 3.56 7.20 5.25 1.14 4.65 0.19 0.26 0.66 0.29 
19 10 20 0.55 TFA 3.03 3.01 7.80 4.90 1.38 4.57 0.23 0.25 0.70 0.42 
20 10 20 0.55 TFA 2.54 3.35 8.10 4.86 1.28 4.95 0.25 0.24 0.78 0.35 
21 5 15 0.1 Perchloratе 5.40 6.37 24.00 15.27 1.42 3.00 0.72 0.57 2.78 1.41 
22 15 15 0.1 Perchlorate 5.38 6.37 20.22 16.79 1.90 2.90 0.72 0.61 2.11 1.51 
23 5 25 0.1 Perchlorate 3.59 2.45 6.05 3.57 0.50 3.39 0.17 0.17 1.12 0.36 
24 15 25 0.1 Perchlorate 6.06 2.14 5.89 4.65 1.20 3.65 0.14 0.14 6.22 0.24 
25 5 15 1 Perchlorate 12.46 20.29 75.00 34.47 1.98 6.76 1.45 1.56 1.65 3.13 
26 15 15 1 Perchlorate 15.67 20.52 70.00 33.09 2.57 8.90 1.17 1.40 0.99 2.43 
27 5 25 1 Perchlorate 3.92 4.03 10.23 5.54 0.74 4.06 0.31 0.36 0.89 0.79 
28 15 25 1 Perchlorate 6.19 3.10 12.26 6.35 1.35 6.56 0.28 0.24 1.92 0.39 
29 5 20 0.55 Perchlorate 6.05 6.94 19.90 10.64 1.52 5.90 0.48 0.42 1.40 0.68 
30 15 20 0.55 Perchlorate 11.95 6.81 18.54 10.50 1.81 7.89 0.44 0.39 3.78 0.66 
31 10 15 0.55 Perchlorate 3.01 13.90 48.79 26.72 2.54 4.91 1.44 0.88 1.20 3.41 
32 10 25 0.55 Perchlorate 3.09 4.07 8.50 5.20 1.40 5.59 0.25 0.22 1.28 0.31 
33 10 20 0.1 Perchlorate 7.12 3.38 8.78 5.88 1.01 2.97 0.31 0.24 3.15 0.59 
34 10 20 1 Perchlorate 6.59 8.03 22.25 11.82 1.23 5.26 0.75 0.53 1.87 1.23 
35 10 20 0.55 Perchlorate 5.12 6.90 16.44 9.36 1.75 4.55 0.47 0.43 1.86 1.07 
36 10 20 0.55 Perchlorate 6.02 6.90 16.35 9.42 1.76 4.55 0.47 0.43 1.91 1.37 
37 10 20 0.55 Perchlorate 6.54 6.95 16.39 9.32 1.75 4.57 0.47 0.43 1.72 0.78 
38 10 20 0.55 Perchlorate 6.36 6.76 16.50 9.30 1.76 4.57 0.47 0.43 1.80 1.25 
39 10 20 0.55 Perchlorate 5.46 6.92 16.50 9.50 1.78 4.55 0.47 0.43 1.85 0.89 
40 10 20 0.55 Perchlorate 6.24 6.90 16.47 9.35 1.75 4.58 0.47 0.43 1.80 1.08 
k – retention factor; Rs – resolution factor; TFA – trifluoroacetic acidHaotropni efekat 
trifluorosirćetne i perhlorne kiseline na formiranje inkluzionih kompleksa između β-ciklodekstrina i 
risperidona, olanzapina i njihovih srodnih supstanci 
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Olanzapine and its related impurity 
The responses analyzed in the case of olanzapine and its related impurity were their 
retention factors, resolution and peak widths. The dependence of each of the investigated 
responses upon investigated parameters was defined through mathematical models 
suggested by Design-Expert software. Mathematical models' equations together with  
values of coefficient of determination (R2, adjusted R2, predicted R2) for each of the 
investigated responses are presented in Table III. Adequacy and validity of each of the 
obtained models were confirmed through non-significant Lack of Fit test and high values 
of coefficient of determination. The retention factor of olanzapine (k) needed to be 
transformed to inverse square root.  
When analyzing the obtained equation (Table III), it could be seen that the most 
influential factors are the type of chaotropic agent, acetonitrile content, β-CD, and 
chaotropic agent concentration, respectively. Taking into account the response 
transformation, acetonitrile content is actually negatively correlated to the olanzapine 
retention factor. Retention factor is reduced with an increase in values of acetonitrile 
content in the mobile phase, which was expected in line with the lipophilic nature of 
olanzapine. However, the increase in β-CD concentration would lead to retention time 
prolongation, which is the opposite to the postulate that the addition of β-CD in the mobile 
phase causes retention reduction (8, 12). When discussing the type of chaotropic agent 
and its content, they were both positively correlated to k. Figure 2 shows the interaction 
between acetonitrile and a chaotropic agent concentration, namely the expected retention 
prolongation with an increase in chaotropic agent concentration is not observed if 
acetonitrile content is high. Although the effect of acetonitrile and chaotrope on retention 
are opposed, with higher acetonitrile percentages, chaotropic mechanisms became 
negligible.  
 
Figure 2. Olanzapine retention factor dependence on chaotrope and acetonitrile content, if  
 trifluoroacetic acid (a) or perchloric acid (b) is used as chaotropic agent 
Slika 2.  Zavisnost retencionog faktora olanzapina od koncentracije haotropa i acetonitrila  
 kada su trifluorosirćetna kiselina (a) i perhlorna kiselina (b) korišćene kao  
 haotropni agensi 
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For the olanzapine impurity retention factor, Design Expert also proposed a 
quadratic model, with square root response transformation (Table III). 
Olanzapine impurity retention factor is mostly influenced by acetonitrile content, 
followed by chaotropic agent concentration, type of chaotropic agent and β-CD 
concentration at last. Both acetonitrile content, and β-CD concentration are showing a 
negative effect on retention factor, although the effect of acetonitrile is more prominent. 
On the other hand, as expected the type of chaotropic agent and the increase in its 
concentration are prolonging the retention.  
Quadratic models were also suggested when analysing Rs of the critical pair 
denoted as olanzapine and its related impurity (Table III).  
Rs between olanzapine and its impurity is the most influenced by acetonitrile 
content, followed by chaotropic agent concentration, the type of chaotropic agent, and 
finally β-CD concentration. Among all factors, only acetonitrile content showed a 
negative influence on Rs. The positive effect of type and content of chaotropic agent on 
Rs is related to their influence on solute distribution equilibrium and reduced peak tailing, 
which contributes to better baseline separation. The aforementioned effect is more 
pronounced when the chaotropic agent concentration is higher and if the chaotropic ion 
from the right-hand side of the Hofmeister series, with greater ability to disrupt a water 
solution shell, is used. When analyzing the interactions, the most profound effect is of the 
interaction between the type of chaotropic agent and β-CD concentration, followed by 
interaction between the type and content of the chaotropic agent.  
 
Figure 3. Rs Olanzapine/Impurity dependence on the type of chaotropic agent and β-CD  
 concentration (a) and the type of chaotropic agent and content (b) 
Slika 3.  Rs Olanzapin/srodna supstanca zavisnost od tipa haotropnog agensa i β-CD  
 koncentracije (a) i vrste i koncentracije haotropnog agensa (b) 
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The first interaction shows positive, while the second one shows a negative effect 
on resolution. If the β-CD concentration is at its higher factor level (+1) resolution factor 
would increase if perchloric acid is chosen over trifluoroacetic acid (Figure 3a). On the 
other hand, if the chaotropic agent content is at its higher level (+1), the resolution factor 
value would be the same, regardless of the type of chaotropic agent (Figure 3b). Rs would 
also be affected by the interaction between acetonitrile content and the type of chaotropic 
agent. It is known from the literature that the choice of organic modifier and its content 
would influence both eluent strength and stationary phase surface microenvironment. In 
that sense, the adsorption of the chaotropic agent would also be affected. Acetonitrile 
tends to form a thick layer on the stationary phase surface (13). Consequently, the 
adsorption of chaotropes is favoured until the point at which further increase in 
acetonitrile content would lead to shorter retention times due to the high elution capacity 
of the mobile phase. The decrease in Rs with an increase in acetonitrile content would be 
lower if perchloric acid is used as a chaotropic agent, instead of trifluoroacetic acid.  
Further, the relations between peak width of olanzapine and its related impurity and 
investigated factors were interpreted by quadratic models with square root transformation 
of the peak width of olanzapine and logarithmic transformation of peak width of the 
impurity (Table III).  
 
Table III  Mathematical models characterizing the relation between change in response of  
 olanzapine and its impurity influenced by the change in the values of the factors  
Tabela III  Matematički modeli koji opisuju zavisnost promene odgovora olanzapina i njemu  
 srodne nečistoće od promena vrednosti ispitivanih faktora 
 
 Mathematical model R2 Adjusted R2 Predicted R2 
Olanzapine k 
1/√k Olanzapine = + 0.50 – 0.046 * A + 0.055 * B - 0.043 * C - 
0.068 * D - 0.022 * A * B + 0.002048 * A * C + 0.009123 * A * 
D + 0.034 * B * C -0.011 * B * D + 0.008908 * C * D - 0.10 * 
A^2 + 0.13 * B^2 - 0.059 * C^2 
0.926 0.889 0.821 
Olanzapine impurity 
k 
√k Olanzapine impurity = + 2.26 - 0.046 * A - 0.80 * B + 0.46 
* C + 0.30 * D - 0.023 * A * B -0.031 * A * C +0.012 * A * D -
0.36 * B * C -0.10 * B * D +0.11 * C * D + 0.018 * A^2 + 0.31 * 
B^2 - 0.21 * C^2 
0.986 0.979 0.962 
Rs 
Olanzapine/Impurity 
Rs olanzapine/impurity = + 1.52 + 0.13 * A - 0.59 * B + 0.32 * 
C + 0.16 * D + 0.017 * A * B - 0.017 * A * C + 0.13 * A * D - 
0.032 * B * C + 0.072 * B * D - 0.13 * C * D - 0.048 * A^2 + 0.22 
* B^2 - 0.38 * C^2 
0.951 0.927 0.878 
Olanzapine peak 
width 
√ Olanzapine peak width = + 0.60 - 0.023 * A - 0.23 * B + 0.082 
* C + 0.076 * D -0.0002054 * A * B + 0.003664 * A * C - 
0.00001177 * A * D - 0.060 * B * C - 0.048 * B * D + 0.038 * C 
* D + 0.0001338 * A^2 + 0.11 * B^2 - 0.011 * C^2 
0.932 0.899 0.792 
Olanzapine impurity 
peak width 
log10 Olanzapine impurity peak width = - 0.49 - 0.029 * A - 0.34 
* B + 0.15 * C + 0.099 * D - 0.021 * A * B - 0.002619 * A * C - 
0.002024 * A * D - 0.031 * B * C + 0.017 * B * D + 0.020 * C * 
D + 0.035 * A^2 + 0.046 * B^2 - 0.035 * C^2 
0.992 0.988 0.977 
A - β-CD concentration in the aqueous part of the mobile phase (mM) 
B - acetonitrile content in the mobile phase (%, v/v) 
C -  the chaotropic agent content (%, v/v) 
D - the type of chaotropic agent used (a – trifluoroacetic, b – perchloric acid) 
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Olanzapine and its impurity peak widths are mostly affected by acetonitrile content 
and the least by β-CD concentration, while both effects are negative. Knowing that 
efficient separation depends on narrow and symmetric peaks, it is desirable to have the 
lowest peak width.  The joint effect of acetonitrile and chaotropic agent concentration 
leads to a reduction in olanzapine peak width.  
Risperidone and its related impurity 
The relation between retention factor (k) of risperidone and its impurity and 
investigated factors was explained with quadratic equations proposed by Design Expert 
(Table 4). Adequacy of the models was confirmed through non-significant Lack of Fit 
tests, while the validity was shown through high values of R2 (both adjusted and 
predicted). Both responses required logarithmic transformation.  
 
Table IV  Mathematical models characterizing the relation between change in response of  
 risperidone and its impurity influenced by the change in the values of the factors  
Tabela IV Matematički modeli koji opisuju zavisnost promene odgovora risperidona i njemu  
 srodne nečistoće od promena vrednosti ispitivanih faktora 
 
 Mathematical model R2 Adjusted R2 Predicted R2 
Risperidone k 
log10 k Risperidone = + 1.06 - 0.010 * A - 0.36 * B + 0.18 * C + 
0.15 * D + 0.025 * A * B + 0.012 * A * C + 0.003383 * A * D - 
0.058 * B * C + 0.012 * B * D + 0.021 * C * D + 0.050 * A^2 + 
0.070 * B^2 - 0.069 * C^2 
0.995 0.992 0.988 
Risperidone impurity 
k 
log10 k Risperidone impurity = +0.85 + 0.005453 * A - 0.34 * B 
+ 0.11 * C + 0.12 * D + 0.016 * A * B - 0.008865 * A * C + 0.014 
* A * D - 0.039 * B * C - 0.002029 * B * D + 0.013 * C * D + 
0.032 * A^2 + 0.085 * B^2 - 0.050 * C^2 
0.995 0.993 0.989 
Rs 
Risperidone/Impurity 
1/Rs Risperidone/impurity = + 0.21 - 0.007669 * A +0.007183 
* B - 0.096 * C - 0.005093 * D - 0.013 * A * B - 0.014 * A * C - 
0.011 * A * D + 0.030 * B * C - 0.006724 * B * D + 0.023 * C * 
D - 0.040 * A^2 + 0.004567 * B^2 + 0.069 * C^2 
0.972 0.958 0.940 
Risperidone peak 
width 
1/Risperidone peak width = + 0.97 - 0.094 * A + 0.56 * B + 
0.021 * C - 0.44 * D - 0.17 * A * B + 0.038 * A * C - 0.033 * A * 
D - 0.047 * B * C - 0.54 * B * D + 0.14 * C * D + 0.006680 * A^2 
+ 0.26 * B^2 - 0.14 * C^2 
0.989 0.983 0.963 
Risperidone impurity 
peak width 
log10 Risperidone impurity peak width = - 0.20 - 0.074 * A - 
0.40 * B + 0.087 * C + 0.17 * D -0.043 * A * B - 0.036 * A * C + 
0.017 * A * D - 0.030 * B * C + 0.014 * B * D +0.056 * C * D 
0.948 0.931 0.907 
A - β-CD concentration in the aqueous part of the mobile phase (mM) 
B - acetonitrile content in the mobile phase (%, v/v) 
C -  the chaotropic agent content (%, v/v) 





Both risperidone and its related impurity k are mostly influenced by acetonitrile 
content, chaotropic agent concentration, type of chaotropic agent, and β-CD 
concentration, respectively. The nature of the influence of each of the factors is in 
accordance with the literature data. When discussing factors' interactions, the most 
significant is the one between acetonitrile and chaotropic agent contents. Another 
interesting interaction is the one between acetonitrile content and β-CD concentration. 
The interaction is worth attention because both factors separately lead to retention 
reduction. However, when β-CD concentration is at its higher factorial level, the 
risperidone retention factor will not be lower if acetonitrile content is also at its higher 
factorial level.  
Analyzing the quadratic model explaining the resolution between risperidone and 
its impurity (Rs), it can be seen that acetonitrile content is negatively correlated with Rs.  
Namely, an increase in acetonitrile content will cause a decrease in Rs. On contrary, 
all other factors are positively correlated contributing to Rs. Among interaction terms, the 
interaction between B and C is distinguishing. If acetonitrile content is at its +1 level, a 
positive effect of chaotropic concentration on Rs will not appear. Also, the effect would 
differ depending on the type of chaotropic agent It would not be the same with 
trifluoroacetic and perchloric acid.  
In the case of risperidone peak width Design Expert also suggested a quadratic 
model with the inverse transformation of the response (Table IV).  
Risperidone peak width is mostly influenced by acetonitrile content and the least 
influenced by the content of the chaotropic agent. Moreover, acetonitrile and chaotropic 
agent concentrations are showing negative, while the type of chaotropic agent and β-CD 
concentration are showing positive effects on peak width. Since one of the goals of each 
chromatographic analysis is obtaining narrow and symmetric peaks, the aspiration is 
towards minimizing the peak width.  
For risperidone impurity peak width Design Expert suggested a two-factor 
interaction model with logarithmic transformation of the response (Table IV).  
 Peak width is mostly influenced by acetonitrile content, while least influenced by 
β-CD concentration, although the increase in both factors induces peak narrowing. 
Among the interaction terms, the interaction between the type of chaotropic agent and 
concentration is distinguishing.  
Derringer’s desirability function 
The aforementioned mathematical models for each of the investigated responses 
could serve for 3D-contour plots creation. Overlapping 3D-contour plots to search for 
optimal separation conditions, when a substantial number of responses is analyzed, is 
very difficult. Moreover, it almost always leads to optimal separation conditions chosen 
as a compromise of many solutions (14). For that reason, to search for optimal separation 
conditions for the presented critical peak pairs, a multicriteria decision-making approach 
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was employed. Within this approach, optimal separation conditions were selected with an 
aid of Derringer’s desirability function.  
According to the desirability scale, optimal ranges for each of the investigated 
responses were defined. For all analytes, the criteria for retention factor was in the range 
of 1 to 10. Desirable values of resolution factor were above 2, which would ensure the 
baseline separation, even if peaks are not of the same size, which is the case when 
separating active compound and impurity (1). The peak width of olanzapine and its 
related impurity was in the domain of obtained experimental results, while peaks of 
risperidone and its related impurity were set to be the narrower possible.  
Desirability function has value 1 when all defined goals are reached. In order to 
visualize the optimal regions, the 3D plot of the global desirability function was 
constructed. Analyzing global desirability function of olanzapine and its impurity against 
acetonitrile content and β-CD concentration, the following conditions for separation are 
selected: acetonitrile content 16% (v/v), trifluoroacetic acid as chaotropic agent type with 
0.95% (v/v) content, and 9 mM β-CD concentration (Figure 4).  
 
 
Figure 4. 3D plot of global desirability function of olanzapine and its impurity against  
 acetonitrile content and β-CD concentration in the mobile phase 
Slika 4.  3D dijagram globalne funkcije poželjnih odgovora za olanzapin i njenu srodnu  




3D plot of global desirability function against acetonitrile content and β-CD 
concentration was also created for risperidone and its related impurity (Figure 5).  
 
 
Figure 5. 3D plot of global desirability function of risperidone and its impurity against  
 acetonitrile content and β-CD concentration in the mobile phase 
Slika 5.  3D dijagram globalne funkcije poželjnih odgovora za risperidon i njegovu srodnu  
 supstancu u odnosu na sadržaj acetonitrila i koncentraciju β-CD u mobilnoj fazi 
 
 
Conditions leading to the achievement of all defined response goals are as follows: 
acetonitrile content 25% (v/v), trifluoroacetic acid as the type of chaotropic agent with 
0.27% (v/v) concentration, and 5mM β-CD concentration. In the case of both critical peak 
pairs, the achievement of defined response goals depends mostly on the acetonitrile 
content in the mobile phase. On the other hand influence of β-CD concentration was much 
lower in comparison to the acetonitrile effect. Chromatograms obtained under optimal 
separation conditions for risperidone and its impurity on one hand and olanzapine and its 









Figure 6. Representative chromatograms obtained under defined optimal chromatographic  
 conditions for (a) risperidone and its related impurity and (b) olanzapine and its  
 related impurity 
Slika 6.  Reprezentativni hromatogram dobijen pod definisanim optimalnim  
 hromatografskim uslovima za (a) risperidon i njegovu srodnu supstancu i (b)  
 olanzapin i njegovu srodnu supstancu 
 
Conclusion 
CD-modified RP-HPLC systems generally show a greater level of complexity in 
comparison to regular RP-HPLC systems, due to multiple interactions that can occur 
between solute and mobile and stationary phase components. Moreover, the chaotropic 
agent is included in the mobile phase simultaneously contributing to the overall system’s 
complexity. As expected, acetonitrile and chaotropic agents are showing inverse effects 
on retention factors. Also, if acetonitrile content in the mobile phase is high, the effect of 
the chaotropic agent becomes negligible. Interactions that investigated analytes are 
forming with either chaotropic agent or acetonitrile outperformed their interactions with 
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β-CD. Therefore, complexation based retention reduction is not fully exposed. 
Nevertheless, the reason to introduce chaotropic agents in this kind of chromatographic 
system was to disrupt the solvation shell around both the solute and β-CD, which could 
contribute to the efficiency of complexation. Optimal separation conditions were obtained 
via desirability function and for olanzapine and its impurity they included the following: 
acetonitrile content 16% (v/v), trifluoroacetic acid as the type of chaotropic agent with 
0.95% (v/v) content, and 9 mM β-CD concentration. Further, optimal separation 
conditions for risperidone and its impurity were 25% (v/v) acetonitrile content in the 
mobile phase, trifluoroacetic acid as the type of chaotropic agent with 0.27% (v/v) 
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Kratak sadržaj 
U novije vreme sve više pažnje se poklanja efikasnom razvoju metode uz istovremenu 
procenu njenih ekoloških karakteristika. Jedna of često primenjivanih strategija za razdvajanje 
baznih jonizacionih supstanci jeste dodatak haotropnih soli u mobilnu fazu. Sa druge strane, 
ekološki prihvatljiva metoda tečne hromatografije može se razviti dodatkom ciklodekstrini (CD) 
kao aditiva mobilne faze. Cilj ovog rada je bio da se istraži mogućnost dodatka haotropnih 
agenasa u mobilnu fazu u kojoj se već nalaze CD. Na ovaj način moglo bi doći do narušavanja 
solvatacionog omotača oko analita, što bi ubrzalo proces kompleksiranja analita i CD. Model 
smeša se sastojala od risperidona, olanzapina i njihovih srodnih supstanci. Metoda je razvijana 
primenom metodologije eksperimentalnog dizajna, dok su optimalni uslovi birani primenom 
Deringerove funkcije poželjnih odgovora. Matematički modeli koji su dobijeni za svaki 
posmatrani odgovor, omogućili su da se ispita pojedinačni i zajednički uticaj koncentracije β-CD, 
tipa i koncentracije haotropnog agensa, kao i količine acetontrila u mobilnoj fazi. Pokazalo se da 
najveći uticaj na retencioni faktor ima količina acetonitrila u mobilnoj fazi. Povećanje 
koncentracije haotropa dovodi do produženja retencionog faktora, ali ukoliko je količina 
acetonitrila u mobilnoj fazi visoka efekat haotropa postaje zanemarljiv. Interakcija između analita 
i β-CD su slabe u poređenju sa interakcijama koje analit ostvaruje sa haotropnim agensom ili 
acetonitrilom, te proces kompleksiranja biva prevaziđen drugim vrstama interakcija u ovom 
komplikovanom sistemu. Iz tog razloga smanjenje retencionog vremena kao posledica 
kompleksiranja ne dolazi do izražaja. Uočeno je i da povećanje koncentracije β-CD dovodila je 
do povećanja rezolucije kritičnih parova. Optimalni hromatografski uslovi odabrani su na osnovu 
3D grafikona Deringerove funkcije poželjnih odgovora. Za razdvajanje olanzapina i njegove 
srodne supstance, optimalni uslovi su obuhvatali 16% acetonitrila, 0,95% trifluorosirćetnu 
kiselinu kao haotropni agens i 9 mM β-CD. Optimalni uslovi u slučaju razdvajanja risperidona i 
njegove srodne supstance obuhvatali su 25% acetonitrila, 0,27% trifluorosirćetne kiseline i 5mM 
β-CD. 
 
Ključne reči: risperidon; olanzapin; haotropni agensi; β-CD;  
   Deringerova funkcija poželjnih odgovora 
 
